Topics: Fibrinolysis, Plasmin, Plasminogen, Tissue plasminogen activator, Kallikrein, Fibrinolysis inhibitors, Fibrinogen degradation products, Fibrin degradation products

Topics: Hemostasis, Hemostasis test, vascular constriction, platelet plug, blood coagulation, enzyme cascade theory, blood clotting, prothrombin activator, fibrinogen, fibrin, plasmin, fibrinolysis, prothrombin, thrombin

Topics: Haemostasis, Vasoconstriction, Platelet plug formation, primary haemostasis, Coagulation, secondary haemostasis, CLOTTING FACTORS, Clot retraction, Clot repair, Fibrinolysis

Topics: Hemostasis, Local vasoconstriction, Formation of blood clot, Fibrinolysis, Anticoagulants, Abnormalities of hemostasis, Thrombocytopenia, Hepatic failure, coagulation pathways

Topics: Antithrombotic properties, Blood coagulation, Fibrinolytic system, fibrinolysis, Glu-plasminogen

Topics: PROTHROMBIN TIME, EDTA, Activated Partial Thromboplastin Time, Thrombin Time, Fibrinogen assay, Dry clot technique of Ingram, Platelet disorder, vascular disorder, prolonged Bleeding time, Clot Solubility test, fibrinolysis

Topics: Haemostasis, Endothelium, platelet, coagulation factor, Fibrinolysis, monitoring haemostasis, coagulation, Hemostasis, Thrombosis, Hemorrhage, Coagulopathy.Primary hemostasis, Secondary hemostasis, subendothelium, Endothelial cells, plasmin, plasminogen, fibrinogen degradation, coagulation system

Topics: Pharmacogenomics, Pharmacoepidemiology, DRUG SPECIFICITY, receptor classification, drug concentration, drug effect, spare receptors, COMPETITIVE ANTAGONISM, Irreversible Competitive Antagonism, Partial Agonists, Constitutive Receptor Activation, Inverse Agonists, two-state receptor model, Biased Agonism, Allosteric Modulation, Chemical Antagonism, Pharmacokinetic Antagonism, Receptor–Response Linkage, Physiological Antagonism, Desensitisation, Tolerance, Altered Drug Metabolism, Binding Reaction, Drug–Receptor Interactions, Receptor mechanisms, Ion Channels, Enzymes, Receptor Proteins, Receptor Heterogeneity, Ligand-Gated Ion Channels, Gating Mechanism, G Protein–Coupled Receptors, Proteinase-Activated Receptors, G proteins, phospholipase C, inositol phosphate system, Inositol phosphates, intracellular calcium, Diacylglycerol, protein kinase, MAP kinase system, GPCR desensitisation, Biopharmaceuticals, Chemical Mediators, Presynaptic Modulation, Postsynaptic Modulation, Cholinergic transmission, Nicotinic Receptors, Acetylcholine, Muscarinic Agonists, Muscarinic Antagonists, Ganglion Stimulants, Ganglion-Blocking Drugs, Neuromuscular-Blocking Drugs, Non-Depolarising Blocking Agents, Depolarising Blocking Agents, Cholinesterase Reactivation, Noradrenergic transmission, Adrenoceptor Agonists, α-Adrenoceptor antagonists, 5-Hydroxytryptamine, migraine, Adenosine, purine, Histamine, local hormone, Eicosanoids, Prostanoids, Leukotrienes, Platelet-Activating Factor, Bradykinin, peptide, Neuropeptides, Cytokine, Interferon, Cannabinoids, Endocannabinoids, Nitric oxide, Ischaemic Heart Disease, Antidysrhythmic Drugs, Myocardial Contraction, Anti-Anginal Drugs, Organic Nitrates, Calcium Antagonists, Endothelin, Vasoactive Drugs, Vasodilator Drugs, heart failure, Atherosclerosis, lipoprotein metabolism, Lipoprotein Transport, Lipid-Lowering Drugs, Fibrates, Haemostasis and thrombosis, Blood Coagulation, Warfarin, Platelet Adhesion, Platelet Activation, Antiplatelet Drugs, Adenosine Receptor Antagonists, Fibrinolysis, Thrombolysis, Fibrinolytic Drugs